US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cellectar Biosciences

3.34

+0.13004.05%

Volume:23.12K

Turnover:77.80K

Market Cap:14.16M

PE:-0.31

High:3.42

Open:3.24

Low:3.24

Close:3.21

52wk High:20.59

52wk Low:2.45

Shares:4.24M

Float Shares:4.06M

Volume Ratio:0.68

T/O Rate:0.57%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-10.6249

EPS(LYR):-41.8902

ROE:-145.42%

ROA:-72.31%

PB:1.89

PE(LYR):-0.08

Loading ...

Overview Company News Filings

Cellectar BioSciences Showcases Pipeline Advancements and Radiotherapeutic Platform in New Corporate Presentation

Cellectar Biosciences To Highlight Strategic Initiatives For 2026

Cellectar Biosciences to highlight company’s 2026 strategic initiatives

Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference

Director John Neis Reports Disposal of Cellectar BioSciences Inc. Common Shares

BRIEF-Cellectar Biosciences Announces Strategic Supply Agreement With Ionetix

Cellectar BioSciences Partners with Ionetix for Alpha-Emitting Isotope Supply

Cellectar Biosciences Inc - Announces Multi-Year Supply Agreement With Ionetix

THOMSON REUTERS

Cellectar Biosciences Announces Strategic Supply Agreement With Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies

THOMSON REUTERS

Cellectar BioSciences Unveils Pipeline Advancements in Phospholipid Drug Conjugate Oncology Therapies

Cellectar BioSciences reports Q3 net loss of $4.4 million

Cellectar Biosciences Q3 net loss narrows to $4.4 mln

Cellectar BioSciences Reports Q3 2025 Financial Results and Advances Oncology Pipeline

Cellectar Biosciences Q3 EPS USD -1.41

THOMSON REUTERS

Cellectar Biosciences Q3 EPS $(1.41) Beats $(2.53) Estimate

Cellectar BioSciences Inc. to Release Third Quarter Financial Results

Cellectar Biosciences Inc expected to post a loss of $2.53 a share - Earnings Preview

Cellectar Says FDA Grants Rare Pediatric Drug Designation for Iopofosine in High-Grade Glioma

MT Newswires Live

Cellectar Biosciences Inc - May Receive Priority Review Voucher

THOMSON REUTERS

Cellectar Biosciences Receives Rare Pediatric Disease Designation From U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CLRB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CLRB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLRB\",,,,,undefined,":{"symbol":"CLRB","market":"US","secType":"STK","nameCN":"Cellectar Biosciences","latestPrice":3.34,"timestamp":1770757200000,"preClose":3.21,"halted":0,"volume":23118,"delay":0,"changeRate":0.040498442367601216,"floatShares":4059000,"shares":4240134,"eps":-10.6249,"marketStatus":"Pre-Mkt","change":0.13,"latestTime":"02-11 07:31:05 EST","open":3.235,"high":3.42,"low":3.235,"amount":77802.265038,"amplitude":0.057632,"askPrice":3.62,"askSize":100,"bidPrice":2.96,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-10.6249,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770820200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.34,"postHourTrading":{"tag":"盘后","latestPrice":3.32,"preClose":3.34,"latestTime":"18:44 EST","volume":481,"amount":1549.8047,"timestamp":1770767044871,"change":-0.02,"changeRate":-0.005988,"amplitude":0.032934},"volumeRatio":0.677331455228393,"impliedVol":1.1856,"impliedVolPercentile":0.9222},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLRB\",,,,,undefined,":{"symbol":"CLRB","floatShares":4059000,"roa":"-72.31%","roe":"-145.42%","lyrEps":-41.890175,"volumeRatio":0.677331455228393,"shares":4240134,"dividePrice":0,"high":3.42,"amplitude":0.057632,"preClose":3.21,"low":3.235,"week52Low":2.45,"pbRate":"1.89","week52High":20.5947,"institutionHeld":0,"latestPrice":3.34,"eps":-10.6249,"divideRate":0,"volume":23118,"delay":0,"ttmEps":-10.6249,"open":3.235,"prevYearClose":2.95,"prevWeekClose":3.04,"prevMonthClose":3.22,"prevQuarterClose":2.95,"fiveDayClose":3.12,"twentyDayClose":3.8,"sixtyDayClose":3.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLRB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"CLRB","fiscalQuarterEnding":"2025/09","expectedEps":-1.91,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-1.41},{"market":"US","date":"2025-08-14","symbol":"CLRB","fiscalQuarterEnding":"2025/06","expectedEps":-3.6,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-3.39},{"market":"US","date":"2025-06-24","symbol":"CLRB","defaultRemindTime":1750771800000,"type":"split","dateTimestamp":1750737600000,"forFactor":30,"toFactor":1,"ratio":30},{"market":"US","date":"2025-05-13","symbol":"CLRB","fiscalQuarterEnding":"2025/03","expectedEps":-0.17,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2025-03-13","symbol":"CLRB","fiscalQuarterEnding":"2024/12","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"pre","actualEps":-0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLRB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLRB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.25,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":4,"updateTime":1747198800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CLRB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CLRB","date":"2026-02-10","current":-0.314356,"percent":0.598207,"low":-7.646498,"twenty":-2.643798,"median":-0.948685,"eighty":-0.52694,"high":-0.193553,"avg":-1.525995,"sd":1.405177,"marketCap":13610830},"quantilePoints":[{"date":"2021-02-12","current":-7.646498,"twenty":-3.439909,"median":-1.512789,"eighty":-0.833511,"marketCap":113619300},{"date":"2021-02-19","current":-7.646498,"twenty":-3.735388,"median":-1.519978,"eighty":-0.840924,"marketCap":113619300},{"date":"2021-02-26","current":-5.688994,"twenty":-3.933888,"median":-1.525018,"eighty":-0.851303,"marketCap":84532759},{"date":"2021-03-05","current":-5.788461,"twenty":-4.336289,"median":-1.533081,"eighty":-0.855652,"marketCap":87372023},{"date":"2021-03-12","current":-6.524566,"twenty":-4.605776,"median":-1.533081,"eighty":-0.860994,"marketCap":98482917},{"date":"2021-03-19","current":-6.29035,"twenty":-4.800064,"median":-1.533081,"eighty":-0.866735,"marketCap":94947632},{"date":"2021-03-26","current":-5.587705,"twenty":-4.999409,"median":-1.535637,"eighty":-0.871509,"marketCap":84341780},{"date":"2021-04-01","current":-5.688083,"twenty":-5.070945,"median":-1.537698,"eighty":-0.879312,"marketCap":85856902},{"date":"2021-04-09","current":-4.951978,"twenty":-5.120251,"median":-1.548792,"eighty":-0.886486,"marketCap":74746008},{"date":"2021-04-16","current":-4.751222,"twenty":-5.120251,"median":-1.558853,"eighty":-0.891503,"marketCap":71715765},{"date":"2021-04-23","current":-5.32003,"twenty":-5.14475,"median":-1.559288,"eighty":-0.900071,"marketCap":80301455},{"date":"2021-04-30","current":-5.286571,"twenty":-5.169249,"median":-1.565438,"eighty":-0.909372,"marketCap":79796414},{"date":"2021-05-07","current":-4.75069,"twenty":-5.219653,"median":-1.572391,"eighty":-0.913472,"marketCap":71707727},{"date":"2021-05-14","current":-3.888071,"twenty":-5.219653,"median":-1.582988,"eighty":-0.918185,"marketCap":68016888},{"date":"2021-05-21","current":-4.430593,"twenty":-5.219653,"median":-1.590841,"eighty":-0.925029,"marketCap":77507616},{"date":"2021-05-28","current":-4.942975,"twenty":-5.219653,"median":-1.593621,"eighty":-0.925029,"marketCap":86471082},{"date":"2021-06-04","current":-4.671714,"twenty":-5.253112,"median":-1.593621,"eighty":-0.925029,"marketCap":81725718},{"date":"2021-06-11","current":-4.249753,"twenty":-5.253112,"median":-1.593621,"eighty":-0.925029,"marketCap":74344040},{"date":"2021-06-18","current":-3.827791,"twenty":-5.253112,"median":-1.593621,"eighty":-0.925029,"marketCap":66962362},{"date":"2021-06-25","current":-3.827791,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":66962362},{"date":"2021-07-02","current":-3.737371,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":65380574},{"date":"2021-07-09","current":-3.52639,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":61689735},{"date":"2021-07-16","current":-3.28527,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":57471634},{"date":"2021-07-23","current":-3.37569,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":59053422},{"date":"2021-07-30","current":-3.28527,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":57471634},{"date":"2021-08-06","current":-3.104429,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":54308058},{"date":"2021-08-13","current":-2.661348,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":52987012},{"date":"2021-08-20","current":-2.511279,"twenty":-5.24642,"median":-1.595195,"eighty":-0.925206,"marketCap":49999161},{"date":"2021-08-27","current":-2.987265,"twenty":-5.239728,"median":-1.596896,"eighty":-0.925383,"marketCap":59475966},{"date":"2021-09-03","current":-3.160965,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":62934297},{"date":"2021-09-10","current":-3.191654,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":63545310},{"date":"2021-09-17","current":-3.099587,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":61712272},{"date":"2021-09-24","current":-2.999848,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":59726481},{"date":"2021-10-01","current":-2.790856,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":55565485},{"date":"2021-10-08","current":-2.606722,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":51899410},{"date":"2021-10-15","current":-2.814486,"twenty":-5.239728,"median":-1.605688,"eighty":-0.925383,"marketCap":56035965},{"date":"2021-10-22","current":-2.760474,"twenty":-5.239728,"median":-1.616414,"eighty":-0.925383,"marketCap":54960583},{"date":"2021-10-29","current":-2.645697,"twenty":-5.239728,"median":-1.622698,"eighty":-0.925383,"marketCap":52675396},{"date":"2021-11-05","current":-2.874023,"twenty":-5.239728,"median":-1.637244,"eighty":-0.925383,"marketCap":57221329},{"date":"2021-11-12","current":-2.424802,"twenty":-5.239728,"median":-1.64287,"eighty":-0.925383,"marketCap":52907581},{"date":"2021-11-19","current":-2.114246,"twenty":-5.239728,"median":-1.670829,"eighty":-0.925383,"marketCap":46131451},{"date":"2021-11-26","current":-2.024355,"twenty":-5.239728,"median":-1.697872,"eighty":-0.926071,"marketCap":44170100},{"date":"2021-12-03","current":-1.710999,"twenty":-5.239728,"median":-1.7177,"eighty":-0.926481,"marketCap":37332869},{"date":"2021-12-10","current":-2.175853,"twenty":-5.233037,"median":-1.731798,"eighty":-0.926567,"marketCap":47475679},{"date":"2021-12-17","current":-1.932225,"twenty":-5.233037,"median":-1.751184,"eighty":-0.932125,"marketCap":42159869},{"date":"2021-12-23","current":-1.960228,"twenty":-5.233037,"median":-1.764108,"eighty":-0.933139,"marketCap":42770882},{"date":"2021-12-31","current":-1.859416,"twenty":-5.233037,"median":-1.80397,"eighty":-0.933139,"marketCap":40571236},{"date":"2022-01-07","current":-1.931665,"twenty":-5.226345,"median":-1.843174,"eighty":-0.933273,"marketCap":42147649},{"date":"2022-01-14","current":-1.957148,"twenty":-5.226345,"median":-1.894678,"eighty":-0.933273,"marketCap":42703670},{"date":"2022-01-21","current":-1.512176,"twenty":-5.226345,"median":-1.894678,"eighty":-0.933273,"marketCap":32994680},{"date":"2022-01-28","current":-1.651912,"twenty":-5.226345,"median":-1.894678,"eighty":-0.933273,"marketCap":36043633},{"date":"2022-02-04","current":-1.597026,"twenty":-5.226345,"median":-1.880422,"eighty":-0.933273,"marketCap":34846048},{"date":"2022-02-11","current":-1.596186,"twenty":-5.226345,"median":-1.841635,"eighty":-0.933273,"marketCap":34827718},{"date":"2022-02-18","current":-1.365159,"twenty":-5.226345,"median":-1.799558,"eighty":-0.933273,"marketCap":29786864},{"date":"2022-02-25","current":-1.343876,"twenty":-5.226345,"median":-1.772988,"eighty":-0.933273,"marketCap":29322494},{"date":"2022-03-04","current":-1.313353,"twenty":-5.226345,"median":-1.754415,"eighty":-0.933273,"marketCap":28656490},{"date":"2022-03-11","current":-1.382521,"twenty":-5.226345,"median":-1.731798,"eighty":-0.933273,"marketCap":30165692},{"date":"2022-03-18","current":-1.512176,"twenty":-5.156037,"median":-1.7177,"eighty":-0.933273,"marketCap":32994680},{"date":"2022-03-25","current":-1.684679,"twenty":-5.125151,"median":-1.705459,"eighty":-0.933273,"marketCap":40638448},{"date":"2022-04-01","current":-1.747497,"twenty":-5.074166,"median":-1.705459,"eighty":-0.933273,"marketCap":42153759},{"date":"2022-04-08","current":-1.672015,"twenty":-5.004293,"median":-1.688068,"eighty":-0.933273,"marketCap":40332941},{"date":"2022-04-14","current":-1.744204,"twenty":-4.988062,"median":-1.677395,"eighty":-0.933273,"marketCap":42074327},{"date":"2022-04-22","current":-1.499772,"twenty":-4.928004,"median":-1.665722,"eighty":-0.933273,"marketCap":36178050},{"date":"2022-04-29","current":-1.35514,"twenty":-4.81659,"median":-1.653084,"eighty":-0.933273,"marketCap":32689168},{"date":"2022-05-06","current":-1.236093,"twenty":-4.81659,"median":-1.642551,"eighty":-0.933273,"marketCap":29817471},{"date":"2022-05-13","current":-0.971537,"twenty":-4.759432,"median":-1.633772,"eighty":-0.932431,"marketCap":23224585},{"date":"2022-05-20","current":-0.922973,"twenty":-4.707882,"median":-1.622321,"eighty":-0.926654,"marketCap":22063661},{"date":"2022-05-27","current":-1.124386,"twenty":-4.59731,"median":-1.616414,"eighty":-0.924784,"marketCap":26878439},{"date":"2022-06-03","current":-1.06317,"twenty":-4.527041,"median":-1.608334,"eighty":-0.924784,"marketCap":25415064},{"date":"2022-06-10","current":-0.988154,"twenty":-4.346201,"median":-1.599718,"eighty":-0.924784,"marketCap":23621804},{"date":"2022-06-17","current":-0.97895,"twenty":-4.102874,"median":-1.595839,"eighty":-0.922973,"marketCap":23401778},{"date":"2022-06-24","current":-1.052051,"twenty":-3.948352,"median":-1.589635,"eighty":-0.922973,"marketCap":25149274},{"date":"2022-07-01","current":-1.052307,"twenty":-3.872252,"median":-1.579478,"eighty":-0.922973,"marketCap":25155384},{"date":"2022-07-08","current":-1.139722,"twenty":-3.827791,"median":-1.572391,"eighty":-0.922973,"marketCap":27245047},{"date":"2022-07-15","current":-1.098824,"twenty":-3.749427,"median":-1.565438,"eighty":-0.922973,"marketCap":26267366},{"date":"2022-07-22","current":-1.265222,"twenty":-3.691644,"median":-1.559288,"eighty":-0.922973,"marketCap":30245118},{"date":"2022-07-29","current":-1.001954,"twenty":-3.538446,"median":-1.559288,"eighty":-0.922973,"marketCap":23951690},{"date":"2022-08-05","current":-1.249205,"twenty":-3.429942,"median":-1.546185,"eighty":-0.922973,"marketCap":31619886},{"date":"2022-08-12","current":-1.419387,"twenty":-3.357606,"median":-1.540179,"eighty":-0.922973,"marketCap":35927523},{"date":"2022-08-19","current":-1.389213,"twenty":-3.28527,"median":-1.537358,"eighty":-0.922973,"marketCap":35163757},{"date":"2022-08-26","current":-1.286645,"twenty":-3.192932,"median":-1.533081,"eighty":-0.922973,"marketCap":32567566},{"date":"2022-09-02","current":-1.264847,"twenty":-3.164709,"median":-1.533081,"eighty":-0.922973,"marketCap":32015822},{"date":"2022-09-09","current":-1.194892,"twenty":-3.130276,"median":-1.533081,"eighty":-0.922973,"marketCap":30245108},{"date":"2022-09-16","current":-1.136958,"twenty":-3.099587,"median":-1.530339,"eighty":-0.922973,"marketCap":28778679},{"date":"2022-09-23","current":-0.905221,"twenty":-3.052825,"median":-1.523319,"eighty":-0.922253,"marketCap":22912961},{"date":"2022-09-30","current":-0.811078,"twenty":-3.002917,"median":-1.516299,"eighty":-0.919318,"marketCap":20530013},{"date":"2022-10-07","current":-0.808664,"twenty":-2.963818,"median":-1.511365,"eighty":-0.913446,"marketCap":20468912},{"date":"2022-10-14","current":-0.50451,"twenty":-2.902195,"median":-1.509279,"eighty":-0.910753,"marketCap":12770157},{"date":"2022-10-21","current":-0.439334,"twenty":-2.829708,"median":-1.506875,"eighty":-0.901903,"marketCap":11120423},{"date":"2022-10-28","current":-0.778645,"twenty":-2.798958,"median":-1.502259,"eighty":-0.894438,"marketCap":19709071},{"date":"2022-11-04","current":-0.649648,"twenty":-2.772857,"median":-1.500323,"eighty":-0.88915,"marketCap":17738164},{"date":"2022-11-11","current":-0.653085,"twenty":-2.722212,"median":-1.495239,"eighty":-0.886133,"marketCap":17832016},{"date":"2022-11-18","current":-0.684021,"twenty":-2.666626,"median":-1.493772,"eighty":-0.878935,"marketCap":18676691},{"date":"2022-11-25","current":-0.65996,"twenty":-2.645329,"median":-1.492014,"eighty":-0.872388,"marketCap":18019722},{"date":"2022-12-02","current":-0.642774,"twenty":-2.617033,"median":-1.486496,"eighty":-0.866735,"marketCap":17550458},{"date":"2022-12-09","current":-0.603245,"twenty":-2.569255,"median":-1.481199,"eighty":-0.86055,"marketCap":16471152},{"date":"2022-12-16","current":-0.464034,"twenty":-2.517725,"median":-1.478305,"eighty":-0.85454,"marketCap":12670117},{"date":"2022-12-23","current":-0.53278,"twenty":-2.478119,"median":-1.47143,"eighty":-0.849991,"marketCap":14547171},{"date":"2022-12-30","current":-0.587777,"twenty":-2.449284,"median":-1.464554,"eighty":-0.84308,"marketCap":16048815},{"date":"2023-01-06","current":-0.635899,"twenty":-2.449284,"median":-1.457678,"eighty":-0.838184,"marketCap":17362753},{"date":"2023-01-13","current":-0.586058,"twenty":-2.449284,"median":-1.456169,"eighty":-0.826732,"marketCap":16001888},{"date":"2023-01-20","current":-0.519031,"twenty":-2.449284,"median":-1.453935,"eighty":-0.822266,"marketCap":14171760},{"date":"2023-01-27","current":-0.529343,"twenty":-2.449284,"median":-1.449641,"eighty":-0.811174,"marketCap":14453318},{"date":"2023-02-03","current":-0.567153,"twenty":-2.449284,"median":-1.441011,"eighty":-0.810112,"marketCap":15485698},{"date":"2023-02-10","current":-0.58434,"twenty":-2.449284,"median":-1.430175,"eighty":-0.799183,"marketCap":15954962},{"date":"2023-02-17","current":-0.574028,"twenty":-2.449284,"median":-1.425071,"eighty":-0.79354,"marketCap":15673404},{"date":"2023-02-24","current":-0.536218,"twenty":-2.449284,"median":-1.416973,"eighty":-0.786486,"marketCap":14641024},{"date":"2023-03-03","current":-0.646211,"twenty":-2.449284,"median":-1.411924,"eighty":-0.781744,"marketCap":17644311},{"date":"2023-03-10","current":-0.548305,"twenty":-2.449284,"median":-1.404643,"eighty":-0.776181,"marketCap":15682216},{"date":"2023-03-17","current":-0.517655,"twenty":-2.449284,"median":-1.395795,"eighty":-0.774082,"marketCap":14805570},{"date":"2023-03-24","current":-0.514249,"twenty":-2.449284,"median":-1.389315,"eighty":-0.768613,"marketCap":14708165},{"date":"2023-03-31","current":-0.487004,"twenty":-2.44707,"median":-1.388277,"eighty":-0.76466,"marketCap":13928925},{"date":"2023-04-06","current":-0.459759,"twenty":-2.449284,"median":-1.388216,"eighty":-0.761326,"marketCap":13149684},{"date":"2023-04-14","current":-0.469976,"twenty":-2.451499,"median":-1.386252,"eighty":-0.754745,"marketCap":13441899},{"date":"2023-04-21","current":-0.509788,"twenty":-2.451499,"median":-1.37818,"eighty":-0.751061,"marketCap":14580564},{"date":"2023-04-28","current":-0.519357,"twenty":-2.451499,"median":-1.37244,"eighty":-0.748983,"marketCap":14854273},{"date":"2023-05-05","current":-0.504032,"twenty":-2.451499,"median":-1.364402,"eighty":-0.736952,"marketCap":14415950},{"date":"2023-05-12","current":-0.442426,"twenty":-2.451499,"median":-1.363468,"eighty":-0.728012,"marketCap":13734114},{"date":"2023-05-19","current":-0.467528,"twenty":-2.451499,"median":-1.363468,"eighty":-0.723003,"marketCap":14513355},{"date":"2023-05-25","current":-0.480079,"twenty":-2.451499,"median":-1.363468,"eighty":-0.717726,"marketCap":14902975},{"date":"2023-06-02","current":-0.511457,"twenty":-2.453713,"median":-1.363468,"eighty":-0.71595,"marketCap":15877026},{"date":"2023-06-09","current":-0.552248,"twenty":-2.453713,"median":-1.363468,"eighty":-0.711716,"marketCap":17143292},{"date":"2023-06-16","current":-0.643244,"twenty":-2.453713,"median":-1.363468,"eighty":-0.707415,"marketCap":19968039},{"date":"2023-06-23","current":-0.608728,"twenty":-2.455927,"median":-1.363468,"eighty":-0.703804,"marketCap":18896583},{"date":"2023-06-30","current":-0.580488,"twenty":-2.455927,"median":-1.363468,"eighty":-0.701226,"marketCap":18019937},{"date":"2023-07-07","current":-0.621279,"twenty":-2.455927,"median":-1.363468,"eighty":-0.698648,"marketCap":19286203},{"date":"2023-07-14","current":-0.564799,"twenty":-2.455927,"median":-1.363468,"eighty":-0.695814,"marketCap":17532912},{"date":"2023-07-21","current":-0.621279,"twenty":-2.455927,"median":-1.364313,"eighty":-0.6926,"marketCap":19286203},{"date":"2023-07-28","current":-0.593667,"twenty":-2.455927,"median":-1.364313,"eighty":-0.689642,"marketCap":18429039},{"date":"2023-08-04","current":-0.555386,"twenty":-2.455927,"median":-1.364313,"eighty":-0.684662,"marketCap":17240697},{"date":"2023-08-11","current":-0.542835,"twenty":-2.455927,"median":-1.364313,"eighty":-0.682685,"marketCap":16851077},{"date":"2023-08-18","current":-0.489643,"twenty":-2.455927,"median":-1.364313,"eighty":-0.677154,"marketCap":15584811},{"date":"2023-08-25","current":-0.547788,"twenty":-2.455927,"median":-1.364313,"eighty":-0.671183,"marketCap":17435507},{"date":"2023-09-01","current":-0.541668,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":17240697},{"date":"2023-09-08","current":-0.703862,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":22403166},{"date":"2023-09-15","current":-0.621235,"twenty":-2.455927,"median":-1.364313,"eighty":-0.67029,"marketCap":19773229},{"date":"2023-09-22","current":-0.670199,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":21331710},{"date":"2023-09-29","current":-0.791504,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":25192695},{"date":"2023-10-06","current":-0.890343,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":28338644},{"date":"2023-10-13","current":-0.840359,"twenty":-2.455927,"median":-1.364313,"eighty":-0.67029,"marketCap":26747702},{"date":"2023-10-20","current":-0.821615,"twenty":-2.455927,"median":-1.364313,"eighty":-0.67029,"marketCap":26151099},{"date":"2023-10-27","current":-0.765383,"twenty":-2.455927,"median":-1.371024,"eighty":-0.671484,"marketCap":24361290},{"date":"2023-11-03","current":-0.749763,"twenty":-2.455927,"median":-1.371024,"eighty":-0.677154,"marketCap":23864121},{"date":"2023-11-10","current":-0.609182,"twenty":-2.455927,"median":-1.371024,"eighty":-0.680681,"marketCap":19389598},{"date":"2023-11-17","current":-0.526803,"twenty":-2.455927,"median":-1.371024,"eighty":-0.67632,"marketCap":19886768},{"date":"2023-11-24","current":-0.68359,"twenty":-2.455927,"median":-1.371024,"eighty":-0.67632,"marketCap":25805482},{"date":"2023-12-01","current":-0.804032,"twenty":-2.455927,"median":-1.371024,"eighty":-0.67632,"marketCap":30352162},{"date":"2023-12-08","current":-0.817053,"twenty":-2.455927,"median":-1.368092,"eighty":-0.676472,"marketCap":30843695},{"date":"2023-12-15","current":-0.862626,"twenty":-2.455927,"median":-1.368092,"eighty":-0.676472,"marketCap":32564061},{"date":"2023-12-22","current":-0.859371,"twenty":-2.455927,"median":-1.368092,"eighty":-0.677154,"marketCap":32441178},{"date":"2023-12-29","current":-0.810543,"twenty":-2.459512,"median":-1.371066,"eighty":-0.68359,"marketCap":30597929},{"date":"2024-01-05","current":-0.921219,"twenty":-2.463098,"median":-1.371108,"eighty":-0.684208,"marketCap":34775959},{"date":"2024-01-12","current":-1.119786,"twenty":-2.463098,"median":-1.371108,"eighty":-0.687735,"marketCap":42271838},{"date":"2024-01-19","current":-1.152338,"twenty":-2.466683,"median":-1.371634,"eighty":-0.695517,"marketCap":43500670},{"date":"2024-01-26","current":-1.168614,"twenty":-2.463098,"median":-1.371108,"eighty":-0.696611,"marketCap":44115086},{"date":"2024-02-02","current":-3.170245,"twenty":-2.47556,"median":-1.37216,"eighty":-0.698541,"marketCap":119676525},{"date":"2024-02-09","current":-2.83144,"twenty":-2.511321,"median":-1.382521,"eighty":-0.705287,"marketCap":106886667},{"date":"2024-02-16","current":-2.895974,"twenty":-2.559581,"median":-1.389315,"eighty":-0.71595,"marketCap":109322830},{"date":"2024-02-23","current":-2.702372,"twenty":-2.602292,"median":-1.395777,"eighty":-0.722058,"marketCap":102014340},{"date":"2024-03-01","current":-3.162178,"twenty":-2.640716,"median":-1.403441,"eighty":-0.725922,"marketCap":119372004},{"date":"2024-03-08","current":-3.28318,"twenty":-2.654096,"median":-1.410827,"eighty":-0.740082,"marketCap":123939810},{"date":"2024-03-15","current":-2.726572,"twenty":-2.68046,"median":-1.424856,"eighty":-0.740082,"marketCap":102927901},{"date":"2024-03-22","current":-3.121844,"twenty":-2.705602,"median":-1.438947,"eighty":-0.740082,"marketCap":117849402},{"date":"2024-03-28","current":-2.914244,"twenty":-2.737044,"median":-1.450802,"eighty":-0.740082,"marketCap":110693172},{"date":"2024-04-05","current":-3.159506,"twenty":-2.768117,"median":-1.453935,"eighty":-0.738597,"marketCap":120009097},{"date":"2024-04-12","current":-3.151013,"twenty":-2.795029,"median":-1.457678,"eighty":-0.738597,"marketCap":119686492},{"date":"2024-04-19","current":-2.581962,"twenty":-2.80756,"median":-1.464554,"eighty":-0.738597,"marketCap":98071950},{"date":"2024-04-26","current":-2.564976,"twenty":-2.8074,"median":-1.472805,"eighty":-0.740082,"marketCap":97426740},{"date":"2024-05-03","current":-3.152301,"twenty":-2.818244,"median":-1.479044,"eighty":-0.740082,"marketCap":119735406},{"date":"2024-05-10","current":-3.057921,"twenty":-2.825242,"median":-1.48319,"eighty":-0.740082,"marketCap":116150513},{"date":"2024-05-17","current":-2.341465,"twenty":-2.840499,"median":-1.488219,"eighty":-0.740082,"marketCap":119376916},{"date":"2024-05-24","current":-2.151616,"twenty":-2.840499,"median":-1.492706,"eighty":-0.740082,"marketCap":109697707},{"date":"2024-05-31","current":-2.137553,"twenty":-2.840499,"median":-1.493972,"eighty":-0.740082,"marketCap":108980728},{"date":"2024-06-07","current":-2.130522,"twenty":-2.840499,"median":-1.493972,"eighty":-0.740082,"marketCap":108622239},{"date":"2024-06-14","current":-2.362559,"twenty":-2.842268,"median":-1.495239,"eighty":-0.738597,"marketCap":120452384},{"date":"2024-06-21","current":-1.968799,"twenty":-2.844036,"median":-1.493972,"eighty":-0.737113,"marketCap":100376987},{"date":"2024-06-28","current":-1.638322,"twenty":-2.848813,"median":-1.495239,"eighty":-0.734086,"marketCap":83527992},{"date":"2024-07-05","current":-1.736762,"twenty":-2.848813,"median":-1.495239,"eighty":-0.734086,"marketCap":88546842},{"date":"2024-07-12","current":-1.736762,"twenty":-2.848813,"median":-1.502259,"eighty":-0.734086,"marketCap":88546842},{"date":"2024-07-15","current":-1.778951,"twenty":-2.848813,"median":-1.502259,"eighty":-0.734086,"marketCap":90697777},{"date":"2024-08-02","current":-1.448474,"twenty":-2.858906,"median":-1.499353,"eighty":-0.726559,"marketCap":73848783},{"date":"2024-08-09","current":-1.357065,"twenty":-2.858906,"median":-1.492382,"eighty":-0.726559,"marketCap":69188423},{"date":"2024-08-16","current":-1.427379,"twenty":-2.858906,"median":-1.489129,"eighty":-0.726559,"marketCap":72773315},{"date":"2024-08-23","current":-1.469568,"twenty":-2.858906,"median":-1.486189,"eighty":-0.726559,"marketCap":74924251},{"date":"2024-08-30","current":-1.539882,"twenty":-2.858906,"median":-1.496239,"eighty":-0.726559,"marketCap":78509143},{"date":"2024-09-06","current":-1.476599,"twenty":-2.858906,"median":-1.504725,"eighty":-0.726559,"marketCap":75282740},{"date":"2024-09-13","current":-1.483631,"twenty":-2.858906,"median":-1.492706,"eighty":-0.726559,"marketCap":75641229},{"date":"2024-09-20","current":-1.483631,"twenty":-2.858906,"median":-1.488453,"eighty":-0.726559,"marketCap":75641229},{"date":"2024-09-27","current":-1.343002,"twenty":-2.858906,"median":-1.483631,"eighty":-0.726559,"marketCap":68471444},{"date":"2024-10-04","current":-1.518788,"twenty":-2.858906,"median":-1.488453,"eighty":-0.726559,"marketCap":77433675},{"date":"2024-10-11","current":-1.476599,"twenty":-2.858906,"median":-1.49236,"eighty":-0.726559,"marketCap":75282740},{"date":"2024-10-18","current":-1.448474,"twenty":-2.858906,"median":-1.49236,"eighty":-0.726559,"marketCap":73848783},{"date":"2024-10-25","current":-1.476599,"twenty":-2.858906,"median":-1.49236,"eighty":-0.726559,"marketCap":75282740},{"date":"2024-10-31","current":-1.525463,"twenty":-2.858906,"median":-1.4952,"eighty":-0.726559,"marketCap":73490294},{"date":"2024-11-08","current":-1.57011,"twenty":-2.859722,"median":-1.504725,"eighty":-0.725908,"marketCap":75641229},{"date":"2024-11-15","current":-1.360507,"twenty":-2.859722,"median":-1.504725,"eighty":-0.734143,"marketCap":72056337},{"date":"2024-11-22","current":-1.27916,"twenty":-2.859722,"median":-1.504725,"eighty":-0.743515,"marketCap":64095123},{"date":"2024-11-29","current":-1.268391,"twenty":-2.859722,"median":-1.504725,"eighty":-0.743515,"marketCap":63555538},{"date":"2024-12-06","current":-1.120138,"twenty":-2.859722,"median":-1.504725,"eighty":-0.743515,"marketCap":56126968},{"date":"2024-12-13","current":-0.217439,"twenty":-2.859722,"median":-1.504725,"eighty":-0.734143,"marketCap":10895235},{"date":"2024-12-20","current":-0.196024,"twenty":-2.859722,"median":-1.504725,"eighty":-0.707279,"marketCap":9822219},{"date":"2024-12-27","current":-0.25269,"twenty":-2.859722,"median":-1.504725,"eighty":-0.696611,"marketCap":12661583},{"date":"2025-01-03","current":-0.267598,"twenty":-2.859722,"median":-1.499772,"eighty":-0.678312,"marketCap":13408567},{"date":"2025-01-10","current":-0.256149,"twenty":-2.860519,"median":-1.4952,"eighty":-0.672905,"marketCap":12834917},{"date":"2025-01-17","current":-0.199483,"twenty":-2.860519,"median":-1.490662,"eighty":-0.663943,"marketCap":9995552},{"date":"2025-01-24","current":-0.200884,"twenty":-2.860519,"median":-1.483631,"eighty":-0.656377,"marketCap":10065711},{"date":"2025-01-31","current":-0.205084,"twenty":-2.860519,"median":-1.476599,"eighty":-0.653085,"marketCap":10276187},{"date":"2025-02-07","current":-0.227322,"twenty":-2.860519,"median":-1.469568,"eighty":-0.649765,"marketCap":11390473},{"date":"2025-02-14","current":-0.258415,"twenty":-2.860519,"median":-1.462536,"eighty":-0.649371,"marketCap":12948445},{"date":"2025-02-21","current":-0.307523,"twenty":-2.860519,"median":-1.455889,"eighty":-0.646211,"marketCap":15409110},{"date":"2025-02-28","current":-0.264392,"twenty":-2.860519,"median":-1.455557,"eighty":-0.642751,"marketCap":13247964},{"date":"2025-03-07","current":-0.281773,"twenty":-2.861316,"median":-1.455505,"eighty":-0.637961,"marketCap":14118874},{"date":"2025-03-14","current":-0.30967,"twenty":-2.861316,"median":-1.455505,"eighty":-0.627475,"marketCap":13805530},{"date":"2025-03-21","current":-0.392876,"twenty":-2.861316,"median":-1.455505,"eighty":-0.621802,"marketCap":17514960},{"date":"2025-03-28","current":-0.372307,"twenty":-2.861316,"median":-1.455505,"eighty":-0.618851,"marketCap":16597970},{"date":"2025-04-04","current":-0.303055,"twenty":-2.861316,"median":-1.455505,"eighty":-0.611866,"marketCap":13510619},{"date":"2025-04-11","current":-0.281969,"twenty":-2.860519,"median":-1.452002,"eighty":-0.605839,"marketCap":12570589},{"date":"2025-04-17","current":-0.292719,"twenty":-2.860519,"median":-1.452002,"eighty":-0.600469,"marketCap":13049820},{"date":"2025-04-25","current":-0.323417,"twenty":-2.861316,"median":-1.455505,"eighty":-0.592686,"marketCap":14418392},{"date":"2025-05-02","current":-0.27308,"twenty":-2.861316,"median":-1.455505,"eighty":-0.58434,"marketCap":12174302},{"date":"2025-05-09","current":-0.259953,"twenty":-2.861316,"median":-1.455505,"eighty":-0.579875,"marketCap":11589088},{"date":"2025-05-16","current":-0.476316,"twenty":-2.861316,"median":-1.455505,"eighty":-0.57508,"marketCap":11690464},{"date":"2025-05-23","current":-0.473125,"twenty":-2.861316,"median":-1.455505,"eighty":-0.567153,"marketCap":11612128},{"date":"2025-05-30","current":-0.495654,"twenty":-2.861316,"median":-1.455505,"eighty":-0.564172,"marketCap":12165087},{"date":"2025-06-06","current":-0.766199,"twenty":-2.861316,"median":-1.448474,"eighty":-0.561109,"marketCap":18805196},{"date":"2025-06-13","current":-0.820458,"twenty":-2.861316,"median":-1.434963,"eighty":-0.561109,"marketCap":20136905},{"date":"2025-06-20","current":-0.686218,"twenty":-2.862113,"median":-1.434411,"eighty":-0.560832,"marketCap":16842194},{"date":"2025-06-27","current":-0.544863,"twenty":-2.862113,"median":-1.427379,"eighty":-0.560279,"marketCap":13372840},{"date":"2025-07-03","current":-0.354382,"twenty":-2.862113,"median":-1.415815,"eighty":-0.559226,"marketCap":8697782},{"date":"2025-07-11","current":-0.36398,"twenty":-2.862113,"median":-1.406445,"eighty":-0.554197,"marketCap":8933347},{"date":"2025-07-18","current":-0.578544,"twenty":-2.862113,"median":-1.392222,"eighty":-0.551409,"marketCap":14199478},{"date":"2025-07-25","current":-0.622778,"twenty":-2.862113,"median":-1.37818,"eighty":-0.551409,"marketCap":15285153},{"date":"2025-08-01","current":-0.563411,"twenty":-2.862113,"median":-1.370772,"eighty":-0.55032,"marketCap":13828063},{"date":"2025-08-08","current":-0.548278,"twenty":-2.862113,"median":-1.356102,"eighty":-0.549652,"marketCap":13456648},{"date":"2025-08-15","current":-0.485305,"twenty":-2.862113,"median":-1.344156,"eighty":-0.548278,"marketCap":14108816},{"date":"2025-08-22","current":-0.492991,"twenty":-2.862113,"median":-1.329467,"eighty":-0.5438,"marketCap":14332259},{"date":"2025-08-29","current":-0.514951,"twenty":-2.862113,"median":-1.314652,"eighty":-0.542135,"marketCap":14970667},{"date":"2025-09-05","current":-0.546792,"twenty":-2.86291,"median":-1.30524,"eighty":-0.539697,"marketCap":15896359},{"date":"2025-09-12","current":-0.579731,"twenty":-2.862113,"median":-1.284536,"eighty":-0.539697,"marketCap":16853971},{"date":"2025-09-19","current":-0.602789,"twenty":-2.862113,"median":-1.278581,"eighty":-0.539697,"marketCap":17524299},{"date":"2025-09-26","current":-0.631336,"twenty":-2.862113,"median":-1.269728,"eighty":-0.539697,"marketCap":18354230},{"date":"2025-10-03","current":-0.636826,"twenty":-2.862113,"median":-1.261912,"eighty":-0.539697,"marketCap":18513832},{"date":"2025-10-10","current":-0.523735,"twenty":-2.862113,"median":-1.245054,"eighty":-0.538608,"marketCap":15226030},{"date":"2025-10-17","current":-0.521539,"twenty":-2.862113,"median":-1.210068,"eighty":-0.538088,"marketCap":15162190},{"date":"2025-10-24","current":-0.415035,"twenty":-2.862113,"median":-1.192478,"eighty":-0.536386,"marketCap":12065911},{"date":"2025-10-31","current":-0.35794,"twenty":-2.862113,"median":-1.167076,"eighty":-0.534695,"marketCap":10406050},{"date":"2025-11-07","current":-0.376606,"twenty":-2.862113,"median":-1.150447,"eighty":-0.531595,"marketCap":10948697},{"date":"2025-11-14","current":-0.315119,"twenty":-2.862113,"median":-1.138828,"eighty":-0.528413,"marketCap":9161154},{"date":"2025-11-21","current":-0.634293,"twenty":-2.862113,"median":-1.127224,"eighty":-0.52694,"marketCap":11957177},{"date":"2025-11-28","current":-0.807487,"twenty":-2.862113,"median":-1.120099,"eighty":-0.52694,"marketCap":15222081},{"date":"2025-12-05","current":-0.854721,"twenty":-2.85129,"median":-1.109333,"eighty":-0.52694,"marketCap":16112509},{"date":"2025-12-12","current":-0.850223,"twenty":-2.823373,"median":-1.100993,"eighty":-0.52694,"marketCap":16027706},{"date":"2025-12-19","current":-0.609551,"twenty":-2.814978,"median":-1.081228,"eighty":-0.52694,"marketCap":11490763},{"date":"2025-12-26","current":-0.620797,"twenty":-2.805842,"median":-1.065406,"eighty":-0.52694,"marketCap":11702769},{"date":"2026-01-02","current":-0.663533,"twenty":-2.792758,"median":-1.056217,"eighty":-0.52694,"marketCap":12508395},{"date":"2026-01-09","current":-0.744507,"twenty":-2.75581,"median":-1.047962,"eighty":-0.52694,"marketCap":14034843},{"date":"2026-01-16","current":-0.820982,"twenty":-2.721585,"median":-1.029047,"eighty":-0.52694,"marketCap":15476489},{"date":"2026-01-23","current":-0.85697,"twenty":-2.702372,"median":-1.013967,"eighty":-0.52694,"marketCap":16154910},{"date":"2026-01-30","current":-0.728762,"twenty":-2.669266,"median":-0.996329,"eighty":-0.52694,"marketCap":13738034},{"date":"2026-02-06","current":-0.634293,"twenty":-2.645451,"median":-0.960674,"eighty":-0.52694,"marketCap":11957177},{"date":"2026-02-10","current":-0.722014,"twenty":-2.643798,"median":-0.948685,"eighty":-0.52694,"marketCap":13610830}],"updateTime":1770807323171},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CLRB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603547142","title":"Cellectar BioSciences Showcases Pipeline Advancements and Radiotherapeutic Platform in New Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2603547142","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603547142?lang=en_us&edition=fundamental","pubTime":"2026-01-13 01:28","pubTimestamp":1768238910,"startTime":"0","endTime":"0","summary":"Cellectar BioSciences Inc. has released a corporate presentation outlining its progress in the development of phospholipid drug conjugates  for oncology. The company's PDC platform enables the delivery of various therapeutic modalities, including radioisotopes, to target both solid and hematologic tumors. Key updates include the initiation of a Phase 1b study of CLR 125 for triple negative breast cancer, and the completion of an Investigational New Drug  package for CLR 225, which is being developed for pancreatic cancer. The presentation also highlights the company's lead asset, iopofosine I 131, which achieved statistically significant response rates in a Phase 2b study for Waldenstrm macroglobulinemia and has received Breakthrough Therapy and PRIME designations in the US and EU, respectively. Plans are underway for regulatory submissions in both regions. Additional pipeline programs and expansion strategies, as well as the company's proprietary manufacturing and supply chain infrast","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL8cyrP4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2602437915","title":"Cellectar Biosciences To Highlight Strategic Initiatives For 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602437915","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602437915?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:44","pubTimestamp":1767966276,"startTime":"0","endTime":"0","summary":"Jan 9 (Reuters) - Cellectar Biosciences Inc ::*CELLECTAR BIOSCIENCES TO HIGHLIGHT STRATEGIC INITIATIVES FOR 2026 AT UPCOMING BIOTECH SHOWCASE DURING 44TH ANNUAL JP MORGAN HEALTHCARE CONFERENCE  ((Reut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nRSD59QGbZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","LU0251132253.USD","LU0238689110.USD","LU1084165304.USD","IE00BFXG1179.USD","LU2213496289.HKD","LU1629891620.HKD","IE00BLSP4452.SGD","LU0345769128.USD","BK4588","LU1974910355.USD","IE00BJTD4N35.SGD","LU1668664300.SGD","LU0006306889.USD","IE00BYXW3230.USD","LU0964807845.USD","LU2023250504.SGD","IE0034235188.USD","LU0345770308.USD","LU0203345920.USD","IE00BDRTCR15.USD","LU2456880835.USD","SG9999002224.SGD","LU0496365809.HKD","LU0942090050.USD","LU1988902786.USD","LU2505996509.AUD","LU0882574139.USD","LU2236285917.USD","LU1496350171.SGD","LU2023250330.USD","LU1894683348.USD","LU0345769631.USD","LU2357305700.SGD","BK4139","LU2237443549.SGD","LU2552382132.HKD","LU0208291251.USD","LU1670628061.USD","LU1280957306.USD","LU1116320901.HKD","LU2430703095.HKD","LU1244550577.SGD","SG9999002232.USD","LU1720051108.HKD","LU1119994496.HKD","BK4504","LU1363072403.SGD","LU2746668461.USD","LU2756315318.SGD"],"gpt_icon":0},{"id":"2602764183","title":"Cellectar Biosciences to highlight company’s 2026 strategic initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2602764183","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602764183?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:16","pubTimestamp":1767964585,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences (CLRB) announces plans to highlight the company’s 2026 strategic initiatives at the upcoming Biotech Showcase, taking place J...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cellectar-biosciences-to-highlight-companys-2026-strategic-initiatives-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cellectar-biosciences-to-highlight-companys-2026-strategic-initiatives-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2602766783","title":"Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2602766783","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602766783?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:05","pubTimestamp":1767963900,"startTime":"0","endTime":"0","summary":"Following Guidance from the European Medicines Agency’s (EMA) Scientific Advice Working Party (SAWP) Regarding Iopofosine I 131 for the Treatment of Waldenstrom’s Macroglobulinemia (WM), Expects to Su","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/09/3216069/29076/en/Cellectar-Biosciences-to-Highlight-Strategic-Initiatives-for-2026-at-Upcoming-Biotech-Showcase-during-44th-Annual-JP-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","XLV","LU0912757837.SGD","LU2023250843.SGD","CNS","LU0795875169.SGD","LU1585245621.USD","BK4581","BK4137","BK4566","LU0106831901.USD","LU0158827948.USD","LU0225283273.USD","LU1430594728.SGD","LU1939255532.USD","LU2362540622.SGD","XBI","LU0106261372.USD","LU1917777945.USD","LU1791710400.SGD","LU1732799900.SGD","IE00BZ1G4Q59.USD","LU1162221912.USD","BK4534","LU0234570918.USD","LU1074936037.SGD","WM","CMA","EMA","LU1363072403.SGD","LU0314104364.USD","CLRB","BK4516","BK4533","BK4139","HCSG","LU0098860793.USD","LU0158827781.USD","LU0069063385.USD","LU0689626769.HKD","LU2106854487.HKD","LU2271345857.HKD","LU0267386448.USD","BK4504","BK4207","LU2347655156.SGD","LU2111349929.HKD","LU2089284900.SGD","LABU","LU1720051017.SGD"],"gpt_icon":0},{"id":"2592953191","title":"Director John Neis Reports Disposal of Cellectar BioSciences Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592953191","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592953191?lang=en_us&edition=fundamental","pubTime":"2025-12-17 07:00","pubTimestamp":1765926047,"startTime":"0","endTime":"0","summary":"John Neis, Director at Cellectar BioSciences Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectar BioSciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL6D8xqg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director John Neis Reports Disposal of Cellectar BioSciences Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2591993865","title":"BRIEF-Cellectar Biosciences Announces Strategic Supply Agreement With Ionetix","url":"https://stock-news.laohu8.com/highlight/detail?id=2591993865","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591993865?lang=en_us&edition=fundamental","pubTime":"2025-12-16 22:35","pubTimestamp":1765895756,"startTime":"0","endTime":"0","summary":"BRIEF-Cellectar Biosciences Announces Strategic Supply Agreement With Ionetix Dec 16 (Reuters) - Cellectar Biosciences Inc CLRB.O:CELLECTAR BIOSCIENCES ANNOUNCES STRATEGIC SUPPLY AGREEMENT WITH IONETI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA5BWPJB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2591899982","title":"Cellectar BioSciences Partners with Ionetix for Alpha-Emitting Isotope Supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2591899982","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591899982?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:05","pubTimestamp":1765890336,"startTime":"0","endTime":"0","summary":"Cellectar BioSciences Inc. has entered into a multi-year strategic supply agreement with Ionetix Corporation to secure clinical and commercial-scale supplies of two key alpha-emitting radioisotopes, Actinium-225  and Astatine-211 . This collaboration will support Cellectar's development of targeted alpha therapies  for cancer treatment, ensuring a reliable source of high-quality isotopes for its drug development programs, including future clinical trials and potential commercial launches. The agreement leverages Ionetix's cyclotron technology and production capabilities to meet the growing demand for these critical isotopes as Cellectar advances its radiotherapeutic pipeline.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectar Bio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL96xGks:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014013.SGD","LU0314104364.USD","BK4588","NDAQ","LU2095319765.USD","IE00BKPKM429.USD","SG9999014021.USD","SG9999014005.SGD","BK4585","SG9999014039.USD","BK4139","CLRB","LU2210150020.SGD"],"gpt_icon":0},{"id":"2591982830","title":"Cellectar Biosciences Inc - Announces Multi-Year Supply Agreement With Ionetix","url":"https://stock-news.laohu8.com/highlight/detail?id=2591982830","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591982830?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:05","pubTimestamp":1765890300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA5BWPJB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2591698288","title":"Cellectar Biosciences Announces Strategic Supply Agreement With Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2591698288","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591698288?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:05","pubTimestamp":1765890300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA5BWPJB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2589843808","title":"Cellectar BioSciences Unveils Pipeline Advancements in Phospholipid Drug Conjugate Oncology Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2589843808","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589843808?lang=en_us&edition=fundamental","pubTime":"2025-12-06 06:49","pubTimestamp":1764974976,"startTime":"0","endTime":"0","summary":"Cellectar BioSciences Inc. has outlined key developments in its phospholipid drug conjugate  platform, highlighting progress in multiple oncology therapeutic programs. The company is advancing its pipeline with a focus on targeted radiotherapeutics, reporting readiness for a Phase 1b/2a study with an Auger emitting therapeutic for triple negative breast cancer and finalizing the investigational new drug  application for CLR 225  in solid tumors. Preclinical data with radiotherapies using isotopes such as Lu177, Pb212, and At211 were also noted. Additionally, Cellectar is optimizing the regulatory strategy for iopofosine I 131, aiming for conditional market authorization in Europe and accelerated approval in the U.S. based on positive Phase 2b data in Waldenstrom's macroglobulinemia. The company plans to pursue further development and commercialization partnerships in the U.S. and EU, as well as collaborations to support asset development. You can access the full presentation through th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDLZ4QTB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2583916567","title":"Cellectar BioSciences reports Q3 net loss of $4.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583916567","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583916567?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:31","pubTimestamp":1763037110,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectar BioSciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 13, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDLb3LzGH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2583567654","title":"Cellectar Biosciences Q3 net loss narrows to $4.4 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2583567654","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583567654?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:29","pubTimestamp":1763036972,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences Q3 net loss narrows to $4.4 mlnOverviewCellectar Biosciences Q3 net loss narrows to $4.4 mln, with reduced R&D and G&A expensesCompany plans to submit EMA application for iopofos","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL1N3WP0HA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2583567878","title":"Cellectar BioSciences Reports Q3 2025 Financial Results and Advances Oncology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2583567878","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583567878?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:20","pubTimestamp":1763036426,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectar BioSciences Inc. published the original content used to generate this news brief via GlobeNewswire  on November 13, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL5l21ff:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4112","IE00BGHQF748.EUR","IE00B64PRP62.GBP","CLRB","NDAQ","LU2210149790.SGD","LU2210150020.SGD","BK4139","LU2095319765.USD","IE00B3QW5Z07.USD","BK4585","BK4588","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2583056229","title":"Cellectar Biosciences Q3 EPS USD -1.41","url":"https://stock-news.laohu8.com/highlight/detail?id=2583056229","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583056229?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:20","pubTimestamp":1763036401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX4C347A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2583564058","title":"Cellectar Biosciences Q3 EPS $(1.41) Beats $(2.53) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583564058","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583564058?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:03","pubTimestamp":1763035384,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(1.41) per share which beat the analyst consensus estimate of $(2.53) by 44.2 percent. This is a 88.25 percent increase over losses of $(12.00) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48829864/cellectar-biosciences-q3-eps-1-41-beats-2-53-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB"],"gpt_icon":0},{"id":"2581093469","title":"Cellectar BioSciences Inc. to Release Third Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093469","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581093469?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:06","pubTimestamp":1762434387,"startTime":"0","endTime":"0","summary":"Cellectar BioSciences Inc. will report third quarter financial results on November 13, 2025. A conference call and webcast to discuss the results will be held the same day at 8:30 a.m. Eastern Time. The results and a replay of the corporate presentation will be available on the Events section of the company's Investor Relations website. Access the webcast using the link: Click HERE.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectar BioSciences Inc. published the original content used to generate this news brief via GlobeNewswire  on November 06, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL5w9zy4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU0314104364.USD","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","CLRB","LU2095319765.USD","NDAQ","BK4139","IE00B64PRP62.GBP","BK4112","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2581701296","title":"Cellectar Biosciences Inc  expected to post a loss of $2.53 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2581701296","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581701296?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:09","pubTimestamp":1762376947,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences Inc  expected to post a loss of $2.53 a share - Earnings Preview Cellectar Biosciences Inc CLRB.OQ CLRB.O is expected to  show no change in quarterly revenue when it reports  res","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nL8N3WH384:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2578414806","title":"Cellectar Says FDA Grants Rare Pediatric Drug Designation for Iopofosine in High-Grade Glioma","url":"https://stock-news.laohu8.com/highlight/detail?id=2578414806","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578414806?lang=en_us&edition=fundamental","pubTime":"2025-10-27 21:12","pubTimestamp":1761570760,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences  said Monday that the US Food and Drug Administration has granted its investigational drug iopofosine I 131 rare pediatric drug designation as a potential treatment for inoperable relapsed or refractory pediatric high-grade glioma.Pediatric high-grade gliomas are a collection of aggressive brain and central nervous system tumors.A phase 1b study of the radioactive isotope treatment showed meaningful improvements in progression-free and overall survival, the company said.The study showed that six patients who received at least a 55 millicurie dose of the treatment experienced an average of 5.4 months of progression-free survival and 8.6 months of overall survival, the company said.Three patients who received additional dosing had an average progression-free survival of 8.1 months and overall survival of 11.5 months, the company added.The treatment was well-tolerated, and its toxicity profile was consistent with the company's previously reported safety data, Cellect","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2578764644","title":"Cellectar Biosciences Inc - May Receive Priority Review Voucher","url":"https://stock-news.laohu8.com/highlight/detail?id=2578764644","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578764644?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:30","pubTimestamp":1761568202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUA9GKV1W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2578364615","title":"Cellectar Biosciences Receives Rare Pediatric Disease Designation From U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma","url":"https://stock-news.laohu8.com/highlight/detail?id=2578364615","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578364615?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:30","pubTimestamp":1761568202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUA9GKV1W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLRB","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}]}}